GL1X · GenesisL1 explorer

MolNFT v1 · #159235 · protein

Crystal structure of myst acetyltransferase domain in complex with inhibitor 34

6OIP · Histone acetyltransferase KAT8: “Crystal structure of myst acetyltransferase domain in complex with inhibitor 34”. X-ray diffraction, 2 ligands (MLS, ZN), 4 pockets (best druggability 0.67). MolNFT v1 #159235 on GenesisL1: 3D…

PDB
6OIP
Type
protein
Length
272 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone acetyltransferase KAT8
EC
2.3.1.48
UniProt
Q9H7Z6
Ligands
MLS, ZN
Pockets
4 · best druggability 0.67

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistone acetyltransferase KAT8 (EC 2.3.1.48)protein27236% helix, 24% strandQ9H7Z6

Ligands and binding sites

  • MLS · 2-fluoro-3-methyl-N'-[(naphthalen-2-yl) sulfonyl]benzohydrazide · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12570.670.8335GOL, MLS
2620.390.8020empty
3980.390.7616empty
4730.340.7620empty

Modifications

Observed in the structure: 1 modified (acetylation).

Compared structures

  • 6OIP · Crystal structure of MYST acetyltransferase domain in complex with inhibitor 34 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9H7Z6 · AlphaFold monomer V2.0 prediction for histone acetyltransferase KAT8 (Q9H7Z6) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.